AM
ATIEH MICHAEL G
Director
BoardM
Insider track record
Board DirectorAcross 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by ATIEH MICHAEL G, Director. Director active across 4 companies, notably Chubb Ltd. Aggregated, 24 disclosures have been logged. Breakdown: 0 buy · 11 sells. Total volume traded: €1.5m. History available since 7 June 2021. The latest transaction was filed on 21 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations24 total
681 sharesCommon SharesSEC:0001193125-26-239332:0
193 shares@ US$330.260.0000% mcap3.6% of flowCommon SharesSEC:0001193125-26-239332:1
578 shares@ US$329.530.0001% mcap10.6% of flowCommon SharesSEC:0001193125-26-239332:2
771 sharesCommon SharesSEC:0001213900-25-045010:0
261 shares@ US$287.494.4% of flowCommon SharesSEC:0001213900-24-075871:0
716 shares@ US$269.7011.5% of flowCommon SharesSEC:0001213900-24-044948:0
718 sharesCommon SharesSEC:0001213900-24-044598:0
750 shares@ US$208.399.2% of flowCommon SharesSEC:0001209191-23-045534:0
955 sharesCommon SharesSEC:0001209191-23-030871:0
18,063 sharesCommon StockSEC:0001209191-23-001059:0
3,573 shares0Common StockSEC:0001209191-22-035057:0
932 sharesCommon SharesSEC:0001209191-22-031272:0
2,944 shares@ US$186.200.0004% mcap50.0% of flowCommon SharesSEC:0001209191-21-052701:0
2,944 shares@ US$186.2030.3% of flowCommon SharesSEC:0001209191-21-052701
3,466 shares0Common StockSEC:0001209191-21-039331:0
3,466 shares0Common StockSEC:0001209191-21-039331
1,083 sharesCommon SharesSEC:0001209191-21-035233:0
1,083 sharesCommon SharesSEC:0001209191-21-035233
425 sharesCommon StockSEC:0001104659-16-088108:0
34 sharesCommon StockSEC:0001104659-16-088108:1
24 sharesCommon StockSEC:0001104659-16-088108:2
45 sharesCommon StockSEC:0001104659-16-088108:3
23 sharesCommon StockSEC:0001104659-16-088108:4
4 sharesCommon StockSEC:0001104659-16-088108:5
About ATIEH MICHAEL G
Michael G. Atieh is a Board Member at Chubb Ltd and Oyster Point Pharma, Inc. He contributes to the governance of these companies by bringing his expertise in finance and strategy. His role is essential in guiding strategic decisions.